Compare ATRC & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | AIN |
|---|---|---|
| Founded | 2000 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2005 | 1994 |
| Metric | ATRC | AIN |
|---|---|---|
| Price | $29.95 | $50.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $51.17 | ★ $60.25 |
| AVG Volume (30 Days) | ★ 545.5K | 292.8K |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $201,630,000.00 | ★ $1,054,132,000.00 |
| Revenue This Year | $15.17 | $1.20 |
| Revenue Next Year | $12.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | 7.29 |
| 52 Week Low | $28.32 | $41.15 |
| 52 Week High | $43.18 | $74.16 |
| Indicator | ATRC | AIN |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 36.39 |
| Support Level | $28.69 | $41.15 |
| Resistance Level | $32.85 | $60.43 |
| Average True Range (ATR) | 1.14 | 1.67 |
| MACD | 0.20 | -0.77 |
| Stochastic Oscillator | 37.59 | 20.83 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.